arrow
P

Philip Choi

division of genome science and cancer
H指数:19
被引数:2,256

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Platelet TREM-Like Transcript-1 (TLT-1) regulation in healthy donors and patients at risk of bleeding and thrombosis.

血小板TREM样转录物-1(TLT-1)在健康供者及出血和血栓风险患者的调控

2026-06-150
OAAI
A Phase 2 Study of Ianalumab in Patients with Primary Immune Thrombocytopenia Previously Treated with at Least Two Lines of Therapy: Interim Results from VAYHIT3

一项关于Ianalumab在既往接受至少两种治疗方案治疗的原发性免疫性血小板减少症患者中的II期研究:VAYHIT3试验的期中结果

BLOOD
IF23.1
2024-11-050
PRE
Standardization of definition and management for bleeding disorder of unknown cause: communication from the SSC of the ISTH

不明原因出血性疾病的定义和管理的标准化: 来自ISTH SSC的交流

2024-07-0110
PRE
The clinicopathological features of thrombosis with thrombocytopenia syndrome following ChAdOx1-S (AZD1222) vaccination and case outcomes in Australia: a population-based study

澳大利亚ChAdOx1-S (AZD1222) 疫苗接种后血栓形成伴血小板减少综合征的临床病理特征和病例结局: 一项基于人群的研究

2023-11-014
OAAI
Assessment of immunological anti-platelet factor 4 antibodies for vaccine-induced thrombotic thrombocytopenia (VITT) in a large Australian cohort: A multicenter study comprising 1284 patients
2022-12-0118
OAAI
A novel flow cytometry procoagulant assay for diagnosis of vaccine-induced immune thrombotic thrombocytopenia
2022-06-1013
OAAI
Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia
2022-04-1474
OA